Skip to search formSkip to main contentSkip to account menu

Strontium-89

Known as: Strontium Sr-89, strontium (89Sr) chloride, strontium 89 
A radioisotope of strontium, a heavy metal found naturally as a non-radioactive element. With a half-life of 50 days, strontium-89 is a beta emitter… 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (3)

MetastronStrontium-89 chloridestrontium chloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Radioisotopes for the palliation of metastatic bone cancer: a systematic review.
Review
2005
Review
2005
Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
Review
2002
Review
2002
Palliative radiotherapy in the treatment of skeletal metastases
Highly Cited
2001
Highly Cited
2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial
Highly Cited
2001
Highly Cited
2001
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.
PURPOSE Plasma vascular endothelial growth factor (VEGF) levels are significantly elevated in patients with hormone-refractory… 
Review
1998
Review
1998
Development, differentiation, and maturation of Kupffer cells
Primitive macrophages first develop in the murine and human yolk sac and then differentiate into fetal macrophages. Primitive or… 
Review
1997
Review
1997
Radiotherapy for palliation of symptoms in incurable cancer.
  • D. Hoegler
  • Current Problems in Cancer
  • 1997
  • Corpus ID: 40098277
Highly Cited
1996
Highly Cited
1996
Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.
A Phase I dose-escalation study using 90Y-CYT-356 monoclonal antibody was performed in 12 patients with hormone-refractory… 
Review
1995
Review
1995
Strontium 89 therapy for the palliation of pain due to osseous metastases.
OBJECTIVE To present the current state of systemic radiopharmaceutical therapy for the palliation of pain in individuals with… 
Highly Cited
1993
Highly Cited
1993
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)